In this edition, we look at new EAULAR recommendations for rheumatoid arthritis, the vagal nerve and more.

Read the full coverage here:

New EULAR recommendations for rheumatoid arthritis keep pace with 'ever-evolving field'

Calabrese: Vagal nerve stimulation a 'tectonic shift' in rheumatoid arthritis management

FDA grants fast track designation to intra-articular GLP-1 analog for knee osteoarthritis

Lupus prevention remains elusive despite new treatments

New agents, combinations make for 'exciting time' in psoriatic arthritis

References:

Calabrese LH. Psychoneuroimmunology 101; How will vagal nerve stimulation affect the rheumatologist's practice. Presented at The Congress of Clinical Rheumatology East; April 30-May 3, 2026; Destin, Florida (hybrid meeting).Healio interviews

Healio interviews

Healio interviews

James JA. Novel treatments for systemic lupus erythematosus. Presented at: Congress of Clinical Rheumatology East; April 30-May 3, 2026; Destin, Florida (hybrid meeting).

Kavanaugh A. Achieving precision medicine in PsA: Novel treatment strategies. Presented at The Congress of Clinical Rheumatology East; April 30-May 3, 2026; Destin, Florida (hybrid meeting).

In this edition, we look at rheumatology visits impacting reproductive health counseling, restrictive Medicare Part D coverage, and more.

Read the full coverage here:

Services targeting rheumatology visits increased reproductive health counseling rates 625%

Medicare Part D coverage of certain rheumatoid arthritis drugs 'restrictive'

DMARD treatment fails to mitigate osteoporosis in rheumatoid arthritis

FDA to 'carefully shepherd' CAR T-cell therapy trials in autoimmune, rheumatic disease

Low pay, longer training requirements hobble pediatric rheumatology workforce numbers

References:

Aritomi T, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70125.

Healio interviews

Healio interviews

Kwon Y, et al. Arthritis Rheumatol. 2026;doi:10.1002/art.70132.

Marcy D, et al. Arthritis Care Res. 2026;doi:10.1002/acr.80014.

In this edition, we look at the impact of GLP-1s on total joint replacement, the safety of NSAID's and more.

Read the full coverage here:

GLP-1s may have profound impact on total joint replacement

NSAID use may be safe prior to total joint arthroplasty

Complication risk may be lower for revision TJA when performed in ASC

Despite improved function, patients with elbow dislocation often report long-term pain

Osteochondral allograft transplant may treat pediatric elbow osteochondritis dissecans

References:

Acuña AJ, et al. Paper 33. Presented at: American Association of Hip and Knee Surgeons Annual Meeting; Oct. 23-26, 2025; Dallas.

Foran JRH, et al. Paper 31. Presented at: American Association of Hip and Knee Surgeons Annual Meeting; Oct. 23-26, 2025; Dallas.

Healio Interviews

Perkins CA, et al. Am J Sports Med. 2025;doi:10.1177/03635465251366903.

Plaisier N, et al. Paper 29. Presented at: Orthopaedic Trauma Association Annual Meeting; Oct. 15-18, 2025; Phoenix.